The effect of PSA frequency and duration on PSA doubling time (PSADT) calculations in men with biochemically recurrent prostate cancer (BRPC) after definitive local therapy.
Channing Judith Paller
No relevant relationships to disclose
Sherlly Xie
No relevant relationships to disclose
Dare Olatoye
No relevant relationships to disclose
Samuel R. Denmeade
No relevant relationships to disclose
Mario A. Eisenberger
No relevant relationships to disclose
Emmanuel S. Antonarakis
No relevant relationships to disclose
Michael Anthony Carducci
No relevant relationships to disclose
Gary L. Rosner
No relevant relationships to disclose